Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma.

Saved in:
Bibliographic Details
Title: Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma.
Authors: Nicolson NG; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD., Tandurella JA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA., Wu LW; Department of Medicine, Johns Hopkins Hospital, Baltimore, MD.; Division of Hematology and Medical Oncology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY., Patel J; Department of Cancer Biology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital and Tays Cancer Centre, Tampere, Finland., Morris E; Department of Medicine, Johns Hopkins Hospital, Baltimore, MD., Seppälä TT; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.; Department of Cancer Biology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital and Tays Cancer Centre, Tampere, Finland., Guinn S; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Zlomke H; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.; Department of Surgery, Medical University of South Carolina, Charleston, SC., Shubert CR; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD., Lafaro KJ; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD., Burns WR; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD., Cameron JL; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD., He J; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD., Fertig EJ; Division of Quantitative Sciences, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD.; Department of Oncology, Cancer Convergence Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Jaffee EM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD.; Department of Oncology, Cancer Convergence Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Zimmerman JW; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD.; Department of Oncology, Cancer Convergence Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Burkhart RA; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.; Department of Oncology, Cancer Convergence Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD.
Source: Annals of surgery [Ann Surg] 2026 Jun 01; Vol. 283 (6), pp. e8-e18. Date of Electronic Publication: 2024 Sep 04.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0372354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1140 (Electronic) Linking ISSN: 00034932 NLM ISO Abbreviation: Ann Surg Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first